390 related articles for article (PubMed ID: 23438193)
61. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
[TBL] [Abstract][Full Text] [Related]
62. MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal.
Liu F; Kong X; Lv L; Gao J
FEBS Lett; 2015 Feb; 589(4):500-6. PubMed ID: 25601564
[TBL] [Abstract][Full Text] [Related]
63. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
Ma L; Lai D; Liu T; Cheng W; Guo L
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
[TBL] [Abstract][Full Text] [Related]
64. Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.
Sukowati CH; Anfuso B; Pascut D; Tiribelli C
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):723-5. PubMed ID: 25920931
[TBL] [Abstract][Full Text] [Related]
65. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma.
Zen Y; Fujii T; Yoshikawa S; Takamura H; Tani T; Ohta T; Nakanuma Y
Am J Pathol; 2007 May; 170(5):1750-62. PubMed ID: 17456779
[TBL] [Abstract][Full Text] [Related]
66. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
67. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
[TBL] [Abstract][Full Text] [Related]
68. Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.
Lingala S; Cui YY; Chen X; Ruebner BH; Qian XF; Zern MA; Wu J
Exp Mol Pathol; 2010 Aug; 89(1):27-35. PubMed ID: 20511115
[TBL] [Abstract][Full Text] [Related]
69. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
70. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells.
Zheng X; Cui D; Xu S; Brabant G; Derwahl M
Int J Oncol; 2010 Aug; 37(2):307-15. PubMed ID: 20596658
[TBL] [Abstract][Full Text] [Related]
71. Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma.
Kohga K; Tatsumi T; Takehara T; Tsunematsu H; Shimizu S; Yamamoto M; Sasakawa A; Miyagi T; Hayashi N
J Hepatol; 2010 Jun; 52(6):872-9. PubMed ID: 20395004
[TBL] [Abstract][Full Text] [Related]
72. Role of OCT4 in cancer stem-like cells and chemotherapy resistance.
Mohiuddin IS; Wei SJ; Kang MH
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165432. PubMed ID: 30904611
[TBL] [Abstract][Full Text] [Related]
73. Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122.
Song K; Kwon H; Han C; Zhang J; Dash S; Lim K; Wu T
Oncotarget; 2015 Dec; 6(38):40822-35. PubMed ID: 26506419
[TBL] [Abstract][Full Text] [Related]
74. ABCG2 expression is correlated neither to side population nor to hematopoietic progenitor function in human umbilical cord blood.
Alt R; Wilhelm F; Pelz-Ackermann O; Egger D; Niederwieser D; Cross M
Exp Hematol; 2009 Feb; 37(2):294-301. PubMed ID: 19101070
[TBL] [Abstract][Full Text] [Related]
75. MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.
Shen WW; Zeng Z; Zhu WX; Fu GH
J Mol Med (Berl); 2013 Aug; 91(8):989-1000. PubMed ID: 23619912
[TBL] [Abstract][Full Text] [Related]
76. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
[TBL] [Abstract][Full Text] [Related]
77. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
[TBL] [Abstract][Full Text] [Related]
78. ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells.
Zhu P; Wang Y; He L; Huang G; Du Y; Zhang G; Yan X; Xia P; Ye B; Wang S; Hao L; Wu J; Fan Z
J Clin Invest; 2015 Oct; 125(10):3795-808. PubMed ID: 26426078
[TBL] [Abstract][Full Text] [Related]
79. Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
Chen WC; Chang YS; Hsu HP; Yen MC; Huang HL; Cho CY; Wang CY; Weng TY; Lai PT; Chen CS; Lin YJ; Lai MD
Oncotarget; 2015 Dec; 6(40):42923-37. PubMed ID: 26556861
[TBL] [Abstract][Full Text] [Related]
80. [Lentivirus-mediated RNA interference of CD133 inhibits the proliferation of CD133(+) liver cancer stem cells and increases their cisplatin chemosensitivity].
Lan X; Wang Y; Cao S; Zou D; Li F; Li S
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1741-7. PubMed ID: 23268401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
